Reddy E Premkumar 4
4 · Onconova Therapeutics, Inc. · Filed May 1, 2018
Insider Transaction Report
Form 4
Reddy E Premkumar
Director
Transactions
- Purchase
Common Stock
2018-04-27+282,350→ 668,182 total - Purchase
Warrant (right to purchase)
2018-04-27+282,350→ 282,350 totalExercise: $0.42From: 2018-04-27→ Series B Convertible Preferred Stock (7,058.75 underlying)
Footnotes (2)
- [F1]The common stock and warrants reported on this Form 4 were acquired in a public offering, by Onconova Therapeutics, Inc. (the Company), of units which included one share of common stock and one warrant. The public offering price for each unit was $0.425. The public offering, during which the Company also sold other securities, was pursuant to the Company's effective registration statement on Form S-1 (File No. 333-224315).
- [F2]The warrants are exercisable immediately at an exercise price of $0.425 per 0.025 share of Series B Convertible Preferred Stock and will expire on the 18-month anniversary of the date on which the Company publicly announces through the filing of a Current Report on Form 8-K that a Charter Amendment, increasing the number of available common shares, has been filed with the Secretary of State of the State of Delaware.